Radnostix, Inc. (OTCQB: INIS) (“Radnostix” or the “Company”), a leader in radioisotope production and nuclear medicine solutions, announces the successful closing of its acquisition of key assets from Lucerno Dynamics, LLC, including the LARA® System technology platform, ELLEXA® Explorer software and associated intellectual property. The product line was originally developed to identify, improve dosimetry of, and reduce the frequency of extravasations of IV administered radiopharmaceuticals. Recently, the product line expanded to include a Real-Time Visualization feature.
Read the full article: Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio //
Source: https://www.prnewswire.com/news-releases/radnostix-acquires-lucerno-dynamics-assets-expanding-radiopharma-medical-device-portfolio-302816984.html